EGFR and non-small cell lung carcinoma: This high incidence of brain involvement in both EGFR-mutated and ALK-rearranged NSCLC highlights a fundamental biological characteristic: these specific driver mutations are not merely oncogenic drivers but also appear to confer an inherent biological advantage to cancer cells for colonizing the central nervous system.